Irritable Bowel Syndrome With Diarrhea Clinical Trials

59 clinical trials for Irritable Bowel Syndrome With Diarrhea across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress — RECRUITING · NA
• Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial — RECRUITING · NA
• Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome — RECRUITING · NA
• Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) — RECRUITING · PHASE1
• A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D — RECRUITING · PHASE3
• B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis — RECRUITING · PHASE1
• Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome — NOT_YET_RECRUITING · NA
• GI Permeability Change in Response to Aquamin® — COMPLETED · PHASE2
• The Role of Fiber in the Prevention and Treatment of Fecal Incontinence — COMPLETED · NA
• Curcumin, Vitamin D and Green Tea in IBS-D — COMPLETED · NA
• Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea — COMPLETED · PHASE4
• Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). — TERMINATED · PHASE2
• The Effects of Carbohydrates in Irritable Bowel Syndrome — COMPLETED · NA
• Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation — WITHDRAWN · PHASE1
• Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1) — COMPLETED · NA
• The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D — COMPLETED · NA
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS — WITHDRAWN
• Safety and Efficacy of a Probiotic Supplement in IBS-D — COMPLETED · NA
• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — COMPLETED · PHASE2
• Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy — COMPLETED · NA
• Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults — OTHER · PHASE2
• Faecal Microbiota Transplantation in Irritable Bowel Syndrome — COMPLETED · NA
• Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome — COMPLETED · NA
• Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) — COMPLETED · PHASE2
• Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome — COMPLETED · NA
• To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea — COMPLETED · PHASE4
• FODMAP Reintroduction in Irritable Bowel Syndrome — COMPLETED · NA
• A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms — COMPLETED · NA
• Efficacy and Safety of Rifaximin With NAC in IBS-D — COMPLETED · PHASE1
• Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) — COMPLETED · PHASE4
• Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea — OTHER · PHASE2
• Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome — COMPLETED · NA
• Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome — OTHER · NA
• To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome — COMPLETED · NA
• Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome — OTHER · PHASE4
• Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1 — COMPLETED · NA
• Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome — COMPLETED · PHASE4
• Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis — OTHER
• A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) — COMPLETED · PHASE2
• Eluxadoline Bile Acid Malabsorption (BAM) Study — COMPLETED · PHASE4
• A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome — COMPLETED · PHASE2
• Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome — COMPLETED · NA
• G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea — OTHER · NA
• Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome — COMPLETED · NA
• The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome — COMPLETED · NA
• Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption — COMPLETED · PHASE2
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea — COMPLETED · PHASE2
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use — COMPLETED · PHASE4
• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) — COMPLETED · PHASE2
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study — COMPLETED · PHASE3

Refine this search